Inventor · disambiguated record
Jan Felix Scholtes
Also filed as: SCHOLTES JAN FELIX
1 granted patent·3 pending applications·0 citations·filing 2022–2024
12Inventor score
Files withXENON PHARMACEUTICALS INC4
Top patents by PatentIndex Score
4 records- 0174US2025214970A1Pyridinylacetamide derivatives as sodium channel activatorsXENON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0270US2025059189A1Pyridine derivatives and their use as sodium channel activatorsXENON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0365US12054486B2Pyridine derivatives and their use as sodium channel activatorsXENON PHARMACEUTICALS INC·Filed 2022·Granted Aug 6, 2024·0 cites·35 claims
- 0464US2023203007A1Pyridinylacetamide derivatives as sodium channel activatorsXENON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jan Felix Scholtes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →